25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

DongKook Pharmaceutical Co. Ltd
Buy, Hold or Sell?

Let's analyze DongKook Pharmaceutical Co. Ltd together

I guess you are interested in DongKook Pharmaceutical Co. Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of DongKook Pharmaceutical Co. Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about DongKook Pharmaceutical Co. Ltd

I send you an email if I find something interesting about DongKook Pharmaceutical Co. Ltd.

1. Quick Overview

1.1. Quick analysis of DongKook Pharmaceutical Co. Ltd (30 sec.)










1.2. What can you expect buying and holding a share of DongKook Pharmaceutical Co. Ltd? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
80.0%

What is your share worth?

Current worth
₩14,479.11
Expected worth in 1 year
₩17,068.88
How sure are you?
95.0%

+ What do you gain per year?

Total Gains per Share
₩2,589.77
Return On Investment
15.2%

For what price can you sell your share?

Current Price per Share
₩17,090.00
Expected price per share
₩15,700 - ₩18,600
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of DongKook Pharmaceutical Co. Ltd (5 min.)




Live pricePrice per Share (EOD)
₩17,090.00

2.2. Growth of DongKook Pharmaceutical Co. Ltd (5 min.)




Is DongKook Pharmaceutical Co. Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$445.6m$354.6m$59.1m14.3%

How much money is DongKook Pharmaceutical Co. Ltd making?

Current yearPrevious yearGrowGrow %
Making money$9.5m$8.2m$1.2m13.5%
Net Profit Margin7.1%6.8%--

How much money comes from the company's main activities?

2.3. Financial Health of DongKook Pharmaceutical Co. Ltd (5 min.)




2.4. Comparing to competitors in the Pharmaceuticals industry (5 min.)




  Industry Rankings (Pharmaceuticals)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of DongKook Pharmaceutical Co. Ltd?

Welcome investor! DongKook Pharmaceutical Co. Ltd's management wants to use your money to grow the business. In return you get a share of DongKook Pharmaceutical Co. Ltd.

First you should know what it really means to hold a share of DongKook Pharmaceutical Co. Ltd. And how you can make/lose money.

Speculation

The Price per Share of DongKook Pharmaceutical Co. Ltd is ₩17,090. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of DongKook Pharmaceutical Co. Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in DongKook Pharmaceutical Co. Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩14,479.11. Based on the TTM, the Book Value Change Per Share is ₩647.44 per quarter. Based on the YOY, the Book Value Change Per Share is ₩254.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of DongKook Pharmaceutical Co. Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.220.0%0.220.0%0.190.0%0.210.0%0.320.0%
Usd Book Value Change Per Share0.790.0%0.450.0%0.180.0%0.230.0%-0.080.0%
Usd Dividend Per Share0.000.0%0.000.0%0.100.0%0.090.0%0.100.0%
Usd Total Gains Per Share0.790.0%0.450.0%0.270.0%0.320.0%0.020.0%
Usd Price Per Share13.05-11.62-10.97-23.73-31.91-
Price to Earnings Ratio15.05-14.36-15.26-27.74-31.87-
Price-to-Total Gains Ratio16.54-40.70-42.67--14.22-59.33-
Price to Book Ratio1.29-1.23-1.36-3.66-4.53-
Price-to-Total Gains Ratio16.54-40.70-42.67--14.22-59.33-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share11.963
Number of shares83
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.09
Usd Book Value Change Per Share0.450.23
Usd Total Gains Per Share0.450.32
Gains per Quarter (83 shares)37.6226.36
Gains per Year (83 shares)150.47105.44
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10150140297695
2030129058152200
3045144088229305
40602590117305410
50752740146381515
60903890175457620
7010531040204534725
8012041190234610830
9013541340263686935
100150514902927621040

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%42.00.00.0100.0%
Book Value Change Per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%38.02.00.095.0%40.02.00.095.2%
Dividend per Share0.00.04.00.0%7.00.05.058.3%15.00.05.075.0%32.00.08.080.0%32.00.010.076.2%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%38.02.00.095.0%40.02.00.095.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of DongKook Pharmaceutical Co. Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1126.872647.443+74%254.002+344%328.049+244%-112.298+110%
Book Value Per Share--14479.11313446.737+8%11526.138+26%10589.031+37%13199.103+10%
Current Ratio--1.9991.853+8%1.935+3%2.357-15%1.885+6%
Debt To Asset Ratio--0.2940.311-6%0.352-16%0.357-18%0.318-8%
Debt To Equity Ratio--0.4740.487-3%0.543-13%0.566-16%0.481-2%
Dividend Per Share----0%137.345-100%125.657-100%138.387-100%
Eps--309.537309.8670%268.201+15%306.624+1%459.068-33%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap150215289400.000-446%819569484800.000729582660400.000+12%688914760200.000+19%1506725380546.810-46%1500404443905.259-45%
Net Profit Margin--0.0670.071-6%0.068-2%0.087-23%0.100-33%
Operating Margin----0%0.019-100%0.076-100%0.069-100%
Operating Ratio--0.8921.228-27%0.877+2%0.749+19%0.769+16%
Pb Ratio1.180-9%1.2871.232+4%1.362-5%3.656-65%4.531-72%
Pe Ratio13.803-9%15.05514.364+5%15.261-1%27.740-46%31.865-53%
Price Per Share17090.000-9%18640.00016595.000+12%15672.500+19%33901.000-45%45584.251-59%
Price To Free Cash Flow Ratio---41.009-100%74.336-100%21.925-100%10.846-100%
Price To Total Gains Ratio15.166-9%16.54140.701-59%42.666-61%-14.222+186%59.332-72%
Quick Ratio---0.636-100%1.527-100%1.957-100%1.791-100%
Return On Assets--0.0150.016-5%0.015+0%0.019-22%0.023-35%
Return On Equity--0.0240.025-2%0.023+5%0.030-20%0.035-30%
Total Gains Per Share--1126.872647.443+74%391.346+188%453.705+148%26.089+4219%
Usd Book Value--445635578.500413820038.770+8%354659133.460+26%327433573.122+36%250495975.951+78%
Usd Book Value Change Per Share--0.7890.453+74%0.178+344%0.230+244%-0.079+110%
Usd Book Value Per Share--10.1359.413+8%8.068+26%7.412+37%9.239+10%
Usd Dividend Per Share----0%0.096-100%0.088-100%0.097-100%
Usd Eps--0.2170.2170%0.188+15%0.215+1%0.321-33%
Usd Free Cash Flow----428251.4640%1119698.470-100%1520084.814-100%3321951.245-100%
Usd Market Cap105150702.580-446%573698639.360510707862.280+12%482240332.140+19%1054707766.383-46%1050283110.734-45%
Usd Price Per Share11.963-9%13.04811.617+12%10.971+19%23.731-45%31.909-59%
Usd Profit--9526881.0009536066.7680%8252465.282+15%9495934.568+0%8073992.889+18%
Usd Revenue--142476546.100133817723.590+6%121239023.505+18%111907648.866+27%85227053.226+67%
Usd Total Gains Per Share--0.7890.453+74%0.274+188%0.318+148%0.018+4219%
 EOD+3 -4MRQTTM+16 -11YOY+22 -95Y+18 -1310Y+16 -15

3.3 Fundamental Score

Let's check the fundamental score of DongKook Pharmaceutical Co. Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1513.803
Price to Book Ratio (EOD)Between0-11.180
Net Profit Margin (MRQ)Greater than00.067
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than11.999
Debt to Asset Ratio (MRQ)Less than10.294
Debt to Equity Ratio (MRQ)Less than10.474
Return on Equity (MRQ)Greater than0.150.024
Return on Assets (MRQ)Greater than0.050.015
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of DongKook Pharmaceutical Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.266
Ma 20Greater thanMa 5017,597.500
Ma 50Greater thanMa 10017,412.800
Ma 100Greater thanMa 20017,611.500
OpenGreater thanClose17,440.000
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About DongKook Pharmaceutical Co. Ltd

DongKook Pharmaceutical Co., Ltd. provides pharmaceutical products in South Korea and internationally. It produces active pharmaceutical ingredients, including propofol, streptokinase, and teicoplanin; disposable syringes; and pills, capsules, and ointments, as well as small volume parentral, large volume parentral, and lyophilized injectable drug injections. The company also offers Teicon, Durakinase, and Lorelin Depot injections; produces various natural product materials, such as black cohosh extract and magnolia extract comprises ETIZM and TECA; and natural herb medicines. In addition, it provides general and prescription-based drugs; medical devices; ETC and cosmetic products; and quasi drugs that include lipossol hydrocare bandage. DongKook Pharmaceutical Co., Ltd. also exports its products to approximately 40 countries, including Japan, Europe, Central and South America, and India. The company was formerly known as UEC & Co., Ltd. and changed its name to DongKook Pharmaceutical Co., Ltd. in March 1982. DongKook Pharmaceutical Co., Ltd. was founded in 1968 and is headquartered in Seoul, South Korea.

Fundamental data was last updated by Penke on 2024-11-18 20:35:07.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is fair priced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit DongKook Pharmaceutical Co. Ltd earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare DongKook Pharmaceutical Co. Ltd to the Pharmaceuticals industry mean.
  • A Net Profit Margin of 6.7% means that ₩0.07 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of DongKook Pharmaceutical Co. Ltd:

  • The MRQ is 6.7%. The company is making a profit. +1
  • The TTM is 7.1%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ6.7%TTM7.1%-0.4%
TTM7.1%YOY6.8%+0.3%
TTM7.1%5Y8.7%-1.6%
5Y8.7%10Y10.0%-1.3%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ6.7%9.8%-3.1%
TTM7.1%9.5%-2.4%
YOY6.8%9.9%-3.1%
5Y8.7%12.9%-4.2%
10Y10.0%12.6%-2.6%
4.3.1.2. Return on Assets

Shows how efficient DongKook Pharmaceutical Co. Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare DongKook Pharmaceutical Co. Ltd to the Pharmaceuticals industry mean.
  • 1.5% Return on Assets means that DongKook Pharmaceutical Co. Ltd generated ₩0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of DongKook Pharmaceutical Co. Ltd:

  • The MRQ is 1.5%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.6%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.5%TTM1.6%-0.1%
TTM1.6%YOY1.5%+0.1%
TTM1.6%5Y1.9%-0.3%
5Y1.9%10Y2.3%-0.4%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5%3.6%-2.1%
TTM1.6%3.5%-1.9%
YOY1.5%5.3%-3.8%
5Y1.9%5.9%-4.0%
10Y2.3%4.9%-2.6%
4.3.1.3. Return on Equity

Shows how efficient DongKook Pharmaceutical Co. Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare DongKook Pharmaceutical Co. Ltd to the Pharmaceuticals industry mean.
  • 2.4% Return on Equity means DongKook Pharmaceutical Co. Ltd generated ₩0.02 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of DongKook Pharmaceutical Co. Ltd:

  • The MRQ is 2.4%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.5%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.4%TTM2.5%0.0%
TTM2.5%YOY2.3%+0.1%
TTM2.5%5Y3.0%-0.6%
5Y3.0%10Y3.5%-0.4%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4%4.6%-2.2%
TTM2.5%4.6%-2.1%
YOY2.3%8.2%-5.9%
5Y3.0%9.1%-6.1%
10Y3.5%10.3%-6.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of DongKook Pharmaceutical Co. Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient DongKook Pharmaceutical Co. Ltd is operating .

  • Measures how much profit DongKook Pharmaceutical Co. Ltd makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare DongKook Pharmaceutical Co. Ltd to the Pharmaceuticals industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of DongKook Pharmaceutical Co. Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY1.9%-1.9%
TTM-5Y7.6%-7.6%
5Y7.6%10Y6.9%+0.7%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.2%-13.2%
TTM-12.0%-12.0%
YOY1.9%12.4%-10.5%
5Y7.6%8.6%-1.0%
10Y6.9%12.1%-5.2%
4.3.2.2. Operating Ratio

Measures how efficient DongKook Pharmaceutical Co. Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • An Operation Ratio of 0.89 means that the operating costs are ₩0.89 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of DongKook Pharmaceutical Co. Ltd:

  • The MRQ is 0.892. The company is less efficient in keeping operating costs low.
  • The TTM is 1.228. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.892TTM1.228-0.336
TTM1.228YOY0.877+0.351
TTM1.2285Y0.749+0.479
5Y0.74910Y0.769-0.020
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8921.225-0.333
TTM1.2281.220+0.008
YOY0.8771.311-0.434
5Y0.7491.249-0.500
10Y0.7691.240-0.471
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of DongKook Pharmaceutical Co. Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if DongKook Pharmaceutical Co. Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A Current Ratio of 2.00 means the company has ₩2.00 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of DongKook Pharmaceutical Co. Ltd:

  • The MRQ is 1.999. The company is able to pay all its short-term debts. +1
  • The TTM is 1.853. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.999TTM1.853+0.146
TTM1.853YOY1.935-0.082
TTM1.8535Y2.357-0.504
5Y2.35710Y1.885+0.472
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9992.213-0.214
TTM1.8532.234-0.381
YOY1.9352.028-0.093
5Y2.3572.199+0.158
10Y1.8851.995-0.110
4.4.3.2. Quick Ratio

Measures if DongKook Pharmaceutical Co. Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare DongKook Pharmaceutical Co. Ltd to the Pharmaceuticals industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of DongKook Pharmaceutical Co. Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.636-0.636
TTM0.636YOY1.527-0.891
TTM0.6365Y1.957-1.321
5Y1.95710Y1.791+0.166
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.926-0.926
TTM0.6360.973-0.337
YOY1.5271.515+0.012
5Y1.9571.591+0.366
10Y1.7911.399+0.392
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of DongKook Pharmaceutical Co. Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of DongKook Pharmaceutical Co. Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare DongKook Pharmaceutical Co. Ltd to Pharmaceuticals industry mean.
  • A Debt to Asset Ratio of 0.29 means that DongKook Pharmaceutical Co. Ltd assets are financed with 29.4% credit (debt) and the remaining percentage (100% - 29.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of DongKook Pharmaceutical Co. Ltd:

  • The MRQ is 0.294. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.311. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.294TTM0.311-0.018
TTM0.311YOY0.352-0.040
TTM0.3115Y0.357-0.046
5Y0.35710Y0.318+0.040
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2940.345-0.051
TTM0.3110.339-0.028
YOY0.3520.333+0.019
5Y0.3570.315+0.042
10Y0.3180.339-0.021
4.5.4.2. Debt to Equity Ratio

Measures if DongKook Pharmaceutical Co. Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare DongKook Pharmaceutical Co. Ltd to the Pharmaceuticals industry mean.
  • A Debt to Equity ratio of 47.4% means that company has ₩0.47 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of DongKook Pharmaceutical Co. Ltd:

  • The MRQ is 0.474. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.487. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.474TTM0.487-0.013
TTM0.487YOY0.543-0.056
TTM0.4875Y0.566-0.079
5Y0.56610Y0.481+0.085
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4740.547-0.073
TTM0.4870.547-0.060
YOY0.5430.499+0.044
5Y0.5660.476+0.090
10Y0.4810.548-0.067
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings DongKook Pharmaceutical Co. Ltd generates.

  • Above 15 is considered overpriced but always compare DongKook Pharmaceutical Co. Ltd to the Pharmaceuticals industry mean.
  • A PE ratio of 15.05 means the investor is paying ₩15.05 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of DongKook Pharmaceutical Co. Ltd:

  • The EOD is 13.803. Based on the earnings, the company is underpriced. +1
  • The MRQ is 15.055. Based on the earnings, the company is fair priced.
  • The TTM is 14.364. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD13.803MRQ15.055-1.252
MRQ15.055TTM14.364+0.691
TTM14.364YOY15.261-0.897
TTM14.3645Y27.740-13.376
5Y27.74010Y31.865-4.125
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD13.80327.863-14.060
MRQ15.05529.844-14.789
TTM14.36427.532-13.168
YOY15.26123.102-7.841
5Y27.74027.577+0.163
10Y31.86529.248+2.617
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of DongKook Pharmaceutical Co. Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM41.009-41.009
TTM41.009YOY74.336-33.328
TTM41.0095Y21.925+19.083
5Y21.92510Y10.846+11.079
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.531-29.531
TTM41.00929.447+11.562
YOY74.33626.360+47.976
5Y21.92531.734-9.809
10Y10.84634.357-23.511
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of DongKook Pharmaceutical Co. Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A PB ratio of 1.29 means the investor is paying ₩1.29 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of DongKook Pharmaceutical Co. Ltd:

  • The EOD is 1.180. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.287. Based on the equity, the company is underpriced. +1
  • The TTM is 1.232. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.180MRQ1.287-0.107
MRQ1.287TTM1.232+0.055
TTM1.232YOY1.362-0.130
TTM1.2325Y3.656-2.423
5Y3.65610Y4.531-0.875
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD1.1804.659-3.479
MRQ1.2873.381-2.094
TTM1.2323.209-1.977
YOY1.3622.597-1.235
5Y3.6563.278+0.378
10Y4.5314.179+0.352
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-06-302023-09-302023-12-312024-03-312024-06-30
Minority Interest  -318,863-47,624-366,487-555,893-922,380619,957-302,4231,083,947781,524



6.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets901,399,974
Total Liabilities264,777,719
Total Stockholder Equity558,607,102
 As reported
Total Liabilities 264,777,719
Total Stockholder Equity+ 558,607,102
Total Assets = 901,399,974

Assets

Total Assets901,399,974
Total Current Assets460,791,139
Long-term Assets440,608,835
Total Current Assets
Total Current Assets  (as reported)460,791,139
Total Current Assets  (calculated)0
+/- 460,791,139
Long-term Assets
Long-term Assets  (as reported)440,608,835
Long-term Assets  (calculated)0
+/- 440,608,835

Liabilities & Shareholders' Equity

Total Current Liabilities230,454,750
Long-term Liabilities34,322,969
Total Stockholder Equity558,607,102
Total Current Liabilities
Total Current Liabilities  (as reported)230,454,750
Total Current Liabilities  (calculated)0
+/- 230,454,750
Long-term Liabilities
Long-term Liabilities  (as reported)34,322,969
Long-term Liabilities  (calculated)0
+/- 34,322,969
Total Stockholder Equity
Total Stockholder Equity (as reported)558,607,102
Total Stockholder Equity (calculated)0
+/- 558,607,102
Other
Common Stock Shares Outstanding 43,968
Net Invested Capital 558,607,102
Net Working Capital 230,336,389



6.3. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
> Total Assets 
222,636,205
227,320,875
239,234,278
244,165,974
247,739,220
258,759,957
266,433,958
274,799,401
285,439,674
297,519,774
309,716,708
325,098,157
327,151,370
339,291,484
366,502,795
373,308,019
390,802,585
408,688,277
434,569,667
480,244,697
507,671,772
518,517,970
540,407,432
544,383,940
572,195,895
623,332,211
653,723,667
663,165,456
684,939,986
717,187,346
715,651,038
750,075,941
747,580,548
740,916,541
760,639,419
768,330,084
792,305,118
804,936,828
824,909,982
839,535,126
866,382,081
901,399,974
901,399,974866,382,081839,535,126824,909,982804,936,828792,305,118768,330,084760,639,419740,916,541747,580,548750,075,941715,651,038717,187,346684,939,986663,165,456653,723,667623,332,211572,195,895544,383,940540,407,432518,517,970507,671,772480,244,697434,569,667408,688,277390,802,585373,308,019366,502,795339,291,484327,151,370325,098,157309,716,708297,519,774285,439,674274,799,401266,433,958258,759,957247,739,220244,165,974239,234,278227,320,875222,636,205
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
250,023,506
266,598,537
271,186,425
283,417,189
293,418,727
304,747,995
300,427,998
321,384,962
330,589,678
347,602,917
339,022,394
354,721,431
375,342,626
403,327,802
398,762,970
409,834,321
422,294,875
401,084,010
420,225,975
388,123,270
380,414,296
387,571,311
385,321,452
389,259,014
396,426,738
406,489,688
419,197,358
437,704,386
460,791,139
460,791,139437,704,386419,197,358406,489,688396,426,738389,259,014385,321,452387,571,311380,414,296388,123,270420,225,975401,084,010422,294,875409,834,321398,762,970403,327,802375,342,626354,721,431339,022,394347,602,917330,589,678321,384,962300,427,998304,747,995293,418,727283,417,189271,186,425266,598,537250,023,5060000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
59,659,242
61,487,960
63,132,130
69,085,598
68,307,355
60,557,939
61,802,286
73,717,090
82,581,015
92,554,653
70,260,219
58,483,861
34,820,271
55,683,008
54,537,378
37,255,977
49,774,909
67,732,560
85,443,962
0
0
0
73,693,491
28,503,713
28,592,669
52,937,170
60,552,271
52,550,477
0
052,550,47760,552,27152,937,17028,592,66928,503,71373,693,49100085,443,96267,732,56049,774,90937,255,97754,537,37855,683,00834,820,27158,483,86170,260,21992,554,65382,581,01573,717,09061,802,28660,557,93968,307,35569,085,59863,132,13061,487,96059,659,2420000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
34,542,130
39,218,070
40,951,010
44,972,000
47,543,760
54,934,350
54,453,080
55,706,007
54,039,005
64,236,450
82,634,291
0
0
114,497,213
119,648,692
130,836,708
123,834,274
89,048,463
83,485,532
59,930,876
76,313,433
85,154,881
30,261,268
63,886,009
64,737,394
33,022,320
33,607,600
36,029,120
0
036,029,12033,607,60033,022,32064,737,39463,886,00930,261,26885,154,88176,313,43359,930,87683,485,53289,048,463123,834,274130,836,708119,648,692114,497,2130082,634,29164,236,45054,039,00555,706,00754,453,08054,934,35047,543,76044,972,00040,951,01039,218,07034,542,1300000000000000
       Net Receivables 
79,037,389
82,117,557
88,331,741
88,101,223
89,444,360
94,425,849
96,522,980
94,780,086
92,160,539
94,007,350
91,352,953
94,983,991
96,589,099
103,861,167
107,681,824
111,141,248
109,925,416
117,475,499
122,016,172
114,211,338
117,723,270
120,665,997
105,241,718
117,115,384
120,893,258
128,532,749
139,517,611
136,983,374
140,256,100
146,243,578
140,684,478
139,299,095
142,966,842
152,143,748
157,113,158
134,407,378
149,250,716
148,972,412
155,961,307
161,106,573
174,791,930
0
0174,791,930161,106,573155,961,307148,972,412149,250,716134,407,378157,113,158152,143,748142,966,842139,299,095140,684,478146,243,578140,256,100136,983,374139,517,611128,532,749120,893,258117,115,384105,241,718120,665,997117,723,270114,211,338122,016,172117,475,499109,925,416111,141,248107,681,824103,861,16796,589,09994,983,99191,352,95394,007,35092,160,53994,780,08696,522,98094,425,84989,444,36088,101,22388,331,74182,117,55779,037,389
       Other Current Assets 
1,860,450
2,357,692
3,770,424
2,819,147
4,021,105
3,524,809
1,602,541
1,436,163
1,883,607
1,545,893
2,149,943
2,272,660
2,863,524
3,055,264
2,995,684
2,703,872
3,285,035
2,962,693
2,515,147
2,843,418
3,393,259
2,399,758
1,904,669
5,393,794
6,254,410
6,081,869
6,483,590
4,716,602
8,371,835
4,459,515
6,291,564
4,457,303
4,751,327
3,759,270
3,821,876
4,723,663
2,626,854
2,697,894
1,672,558
1,348,143
1,230,051
0
01,230,0511,348,1431,672,5582,697,8942,626,8544,723,6633,821,8763,759,2704,751,3274,457,3036,291,5644,459,5158,371,8354,716,6026,483,5906,081,8696,254,4105,393,7941,904,6692,399,7583,393,2592,843,4182,515,1472,962,6933,285,0352,703,8722,995,6843,055,2642,863,5242,272,6602,149,9431,545,8931,883,6071,436,1631,602,5413,524,8094,021,1052,819,1473,770,4242,357,6921,860,450
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
383,008,632
403,046,104
408,510,090
418,420,294
420,337,768
428,677,696
440,608,835
440,608,835428,677,696420,337,768418,420,294408,510,090403,046,104383,008,63200000000000000000000000000000000000
       Property Plant Equipment 
43,456,303
45,290,900
46,271,842
53,397,849
53,085,911
52,181,101
54,007,895
56,936,353
56,599,749
56,783,829
58,353,695
62,788,341
62,557,267
62,887,980
65,980,085
69,427,667
72,517,242
79,383,315
87,978,738
140,740,238
144,398,264
145,700,308
148,966,828
158,074,334
162,575,117
181,242,656
183,515,983
194,967,459
202,634,340
215,001,011
224,259,351
234,941,272
259,010,414
258,262,726
261,484,148
263,355,279
265,352,832
268,798,100
272,145,529
272,704,584
273,021,556
0
0273,021,556272,704,584272,145,529268,798,100265,352,832263,355,279261,484,148258,262,726259,010,414234,941,272224,259,351215,001,011202,634,340194,967,459183,515,983181,242,656162,575,117158,074,334148,966,828145,700,308144,398,264140,740,23887,978,73879,383,31572,517,24269,427,66765,980,08562,887,98062,557,26762,788,34158,353,69556,783,82956,599,74956,936,35354,007,89552,181,10153,085,91153,397,84946,271,84245,290,90043,456,303
       Goodwill 
1,327,988
1,053,282
1,053,282
1,053,282
1,053,282
1,053,282
1,053,282
1,053,282
1,053,282
1,053,282
1,053,282
1,053,282
1,053,282
1,053,282
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000001,053,2821,053,2821,053,2821,053,2821,053,2821,053,2821,053,2821,053,2821,053,2821,053,2821,053,2821,053,2821,053,2821,327,988
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
12,621,363
20,332,169
20,563,187
22,796,358
23,591,296
28,688,781
27,626,789
28,506,811
30,822,344
31,694,142
35,482,884
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000035,482,88431,694,14230,822,34428,506,81127,626,78928,688,78123,591,29622,796,35820,563,18720,332,16912,621,3630000000000000
       Intangible Assets 
5,479,709
5,176,627
5,152,833
5,023,811
5,041,955
4,826,979
5,280,422
5,249,906
5,220,618
5,338,485
5,312,434
5,282,883
5,254,187
5,225,332
4,357,225
4,326,065
4,283,981
4,256,334
4,474,687
4,358,895
4,333,333
4,309,936
4,288,024
4,243,747
5,120,450
5,357,577
5,326,226
7,299,252
7,400,914
7,387,022
7,358,037
6,915,535
8,239,569
8,242,682
8,222,213
10,873,371
12,533,472
13,737,194
14,588,839
16,162,484
17,501,747
0
017,501,74716,162,48414,588,83913,737,19412,533,47210,873,3718,222,2138,242,6828,239,5696,915,5357,358,0377,387,0227,400,9147,299,2525,326,2265,357,5775,120,4504,243,7474,288,0244,309,9364,333,3334,358,8954,474,6874,256,3344,283,9814,326,0654,357,2255,225,3325,254,1875,282,8835,312,4345,338,4855,220,6185,249,9065,280,4224,826,9795,041,9555,023,8115,152,8335,176,6275,479,709
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,541
965
853
26,820
802
3,317
0
03,31780226,8208539652,54100000000000000000000000000000000000
> Total Liabilities 
58,792,479
60,571,816
66,400,018
67,600,937
67,711,830
73,547,269
73,391,267
74,184,569
79,105,012
81,615,914
82,220,019
86,761,204
84,073,197
87,343,158
100,720,003
93,813,084
107,954,441
114,328,238
115,321,325
148,632,650
167,690,097
164,430,682
192,574,148
181,509,444
200,056,113
237,691,541
250,957,284
251,797,142
266,472,065
287,320,826
277,201,958
295,510,040
285,558,395
262,975,652
271,317,400
266,390,637
279,626,004
282,253,788
260,015,491
263,361,424
279,386,593
264,777,719
264,777,719279,386,593263,361,424260,015,491282,253,788279,626,004266,390,637271,317,400262,975,652285,558,395295,510,040277,201,958287,320,826266,472,065251,797,142250,957,284237,691,541200,056,113181,509,444192,574,148164,430,682167,690,097148,632,650115,321,325114,328,238107,954,44193,813,084100,720,00387,343,15884,073,19786,761,20482,220,01981,615,91479,105,01274,184,56973,391,26773,547,26967,711,83067,600,93766,400,01860,571,81658,792,479
   > Total Current Liabilities 
46,318,241
47,773,075
53,091,819
52,772,597
53,135,137
57,582,591
58,042,890
58,834,341
64,062,885
65,744,147
67,085,338
72,887,942
69,891,277
73,546,181
86,685,840
80,181,869
93,305,318
98,653,043
99,337,421
92,366,599
108,846,518
106,094,724
98,737,270
110,010,983
127,566,700
131,876,943
141,894,509
144,966,483
157,342,081
160,961,814
146,469,112
220,269,073
182,088,471
176,489,845
185,306,769
198,539,155
210,727,492
213,081,038
220,656,058
231,153,366
248,977,026
230,454,750
230,454,750248,977,026231,153,366220,656,058213,081,038210,727,492198,539,155185,306,769176,489,845182,088,471220,269,073146,469,112160,961,814157,342,081144,966,483141,894,509131,876,943127,566,700110,010,98398,737,270106,094,724108,846,51892,366,59999,337,42198,653,04393,305,31880,181,86986,685,84073,546,18169,891,27772,887,94267,085,33865,744,14764,062,88558,834,34158,042,89057,582,59153,135,13752,772,59753,091,81947,773,07546,318,241
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
5,516,865
12,619,436
9,874,528
8,738,359
13,566,578
0
0
0
0
15,202,139
15,018,045
15,412,003
15,206,312
14,212,528
13,854,030
14,335,872
14,497,796
13,229,733
82,190,851
36,913,374
40,261,821
41,220,634
36,954,477
35,329,874
37,600,000
0
0
0
0
000037,600,00035,329,87436,954,47741,220,63440,261,82136,913,37482,190,85113,229,73314,497,79614,335,87213,854,03014,212,52815,206,31215,412,00315,018,04515,202,139000013,566,5788,738,3599,874,52812,619,4365,516,8650000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
5,516,865
12,619,436
9,874,528
8,738,359
13,566,578
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
36,954,477
35,329,874
37,600,000
40,385,599
53,957,064
46,791,660
0
046,791,66053,957,06440,385,59937,600,00035,329,87436,954,4770000000000000000013,566,5788,738,3599,874,52812,619,4365,516,8650000000000000
       Accounts payable 
13,500,478
15,896,085
15,290,793
17,140,915
18,884,683
21,465,925
19,337,340
18,108,098
19,387,636
20,187,860
21,798,141
21,048,220
18,490,227
22,713,531
21,565,837
20,263,175
21,549,099
19,776,827
18,462,019
18,055,737
22,947,856
24,716,626
19,589,827
17,057,208
20,486,420
24,581,038
31,200,229
26,523,233
28,490,597
34,452,687
27,929,709
29,170,755
24,324,633
28,226,915
28,784,013
33,405,468
37,193,973
37,921,409
64,161,367
62,069,191
81,647,148
0
081,647,14862,069,19164,161,36737,921,40937,193,97333,405,46828,784,01328,226,91524,324,63329,170,75527,929,70934,452,68728,490,59726,523,23331,200,22924,581,03820,486,42017,057,20819,589,82724,716,62622,947,85618,055,73718,462,01919,776,82721,549,09920,263,17521,565,83722,713,53118,490,22721,048,22021,798,14120,187,86019,387,63618,108,09819,337,34021,465,92518,884,68317,140,91515,290,79315,896,08513,500,478
       Other Current Liabilities 
28,161,899
28,824,031
33,296,561
31,140,092
30,710,903
31,954,133
32,178,502
33,763,601
38,734,421
41,665,755
41,805,507
46,704,191
46,894,918
45,727,785
53,280,267
50,404,106
63,377,800
63,461,782
63,849,515
57,435,509
66,030,770
62,280,431
58,197,931
74,023,518
86,114,959
87,700,254
90,570,687
99,945,060
109,824,201
106,682,195
100,147,481
103,260,344
114,518,892
101,831,105
109,885,158
1
0
1
0
-1
0
0
00-10101109,885,158101,831,105114,518,892103,260,344100,147,481106,682,195109,824,20199,945,06090,570,68787,700,25486,114,95974,023,51858,197,93162,280,43166,030,77057,435,50963,849,51563,461,78263,377,80050,404,10653,280,26745,727,78546,894,91846,704,19141,805,50741,665,75538,734,42133,763,60132,178,50231,954,13330,710,90331,140,09233,296,56128,824,03128,161,899
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
38,726,525
39,660,509
39,619,183
39,359,433
32,208,057
30,409,567
34,322,969
34,322,96930,409,56732,208,05739,359,43339,619,18339,660,50938,726,52500000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
54,694,139
43,199,335
42,803,822
67,864,022
68,988,376
52,114,817
52,891,043
68,764,872
72,351,679
13,687,325
40,937,175
23,158,619
22,871,417
27,448,968
27,446,334
27,159,317
0
0
0
0
000027,159,31727,446,33427,448,96822,871,41723,158,61940,937,17513,687,32572,351,67968,764,87252,891,04352,114,81768,988,37667,864,02242,803,82243,199,33554,694,1390000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
-5,516,865
-12,619,436
-9,874,528
-8,738,359
-13,566,578
0
0
0
0
-15,202,139
-15,018,045
-15,412,003
-15,206,312
-14,212,528
-13,854,030
-14,335,872
-14,497,796
-13,229,733
-82,190,851
-36,913,374
-40,261,821
-41,220,634
-32,551,704
-30,562,010
-33,104,860
4,160,959
3,996,892
3,760,652
0
03,760,6523,996,8924,160,959-33,104,860-30,562,010-32,551,704-41,220,634-40,261,821-36,913,374-82,190,851-13,229,733-14,497,796-14,335,872-13,854,030-14,212,528-15,206,312-15,412,003-15,018,045-15,202,1390000-13,566,578-8,738,359-9,874,528-12,619,436-5,516,8650000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
0
0
0
0
0
0
000000-100000000000000000000000000000000000
> Total Stockholder Equity
163,499,204
166,591,161
172,593,767
176,309,388
178,932,026
184,121,278
191,989,602
199,617,215
205,310,766
214,862,900
226,435,546
237,315,240
242,049,658
251,022,133
252,762,108
263,938,838
267,807,813
278,394,505
300,556,793
312,637,532
320,336,258
332,478,679
347,833,284
362,874,496
372,139,782
385,640,670
402,766,383
411,368,313
418,467,921
429,866,520
438,449,080
454,565,901
462,022,152
477,940,889
489,322,019
501,939,447
512,679,114
522,683,040
534,969,845
544,694,047
555,989,630
558,607,102
558,607,102555,989,630544,694,047534,969,845522,683,040512,679,114501,939,447489,322,019477,940,889462,022,152454,565,901438,449,080429,866,520418,467,921411,368,313402,766,383385,640,670372,139,782362,874,496347,833,284332,478,679320,336,258312,637,532300,556,793278,394,505267,807,813263,938,838252,762,108251,022,133242,049,658237,315,240226,435,546214,862,900205,310,766199,617,215191,989,602184,121,278178,932,026176,309,388172,593,767166,591,161163,499,204
   Common Stock
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
22,230,000
0
0
0
0
000022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,00022,230,000
   Retained Earnings Total Equity000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,855,605
12,902,908
12,784,947
12,940,446
12,940,446
13,047,360
13,070,549
13,149,001
13,241,722
13,213,218
13,108,280
13,108,280
13,029,529
13,041,767
15,390,592
15,376,134
0
0
0
0
000015,376,13415,390,59213,041,76713,029,52913,108,28013,108,28013,213,21813,241,72213,149,00113,070,54913,047,36012,940,44612,940,44612,784,94712,902,90812,855,6050000000000000000000000
   Treasury Stock0000000000-3,138,426-3,138,426-3,138,426-3,138,426-3,138,426-3,138,426-3,138,426-3,138,426-3,138,426-3,138,426000-3,138,426-3,138,426-3,138,426-3,138,426-3,138,426-3,138,426-3,138,426-3,138,426-3,138,426-3,138,426-3,138,426-3,138,426-3,138,426-3,138,426-3,138,426-3,000,277-3,000,277-2,892,021-1,341,190
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
935,784
839,856
733,023
704,270
514,166
599,992
869,512
869,511
869,512
1,245,479
869,512
869,512
869,511
963,728
869,512
869,512
869,512
869,512
869,512
869,512
869,512
869,512
1,329,102
1,329,101
1,378,664
0
0
0
0
00001,378,6641,329,1011,329,102869,512869,512869,512869,512869,512869,512869,512869,512963,728869,511869,512869,5121,245,479869,512869,511869,512599,992514,166704,270733,023839,856935,7840000000000000



6.4. Balance Sheets

Currency in KRW. All numbers in thousands.




6.5. Cash Flows

Currency in KRW. All numbers in thousands.




6.6. Income Statements

Currency in KRW. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue730,993,597
Cost of Revenue-320,212,652
Gross Profit410,780,945410,780,945
 
Operating Income (+$)
Gross Profit410,780,945
Operating Expense-664,120,292
Operating Income66,873,305-253,339,347
 
Operating Expense (+$)
Research Development25,455,619
Selling General Administrative239,359,317
Selling And Marketing Expenses0
Operating Expense664,120,292264,814,936
 
Net Interest Income (+$)
Interest Income5,254,515
Interest Expense-5,867,708
Other Finance Cost-1
Net Interest Income-613,194
 
Pretax Income (+$)
Operating Income66,873,305
Net Interest Income-613,194
Other Non-Operating Income Expenses0
Income Before Tax (EBT)60,837,64266,873,305
EBIT - interestExpense = -5,867,708
47,175,203
53,042,911
Interest Expense5,867,708
Earnings Before Interest and Taxes (EBIT)066,705,350
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax60,837,642
Tax Provision-11,966,256
Net Income From Continuing Ops48,871,38648,871,386
Net Income47,175,203
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0613,194
 

Technical Analysis of DongKook Pharmaceutical Co. Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of DongKook Pharmaceutical Co. Ltd. The general trend of DongKook Pharmaceutical Co. Ltd is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine DongKook Pharmaceutical Co. Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of DongKook Pharmaceutical Co. Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 18,400 < 18,400 < 18,600.

The bearish price targets are: 16,240 > 16,130 > 15,700.

Tweet this
DongKook Pharmaceutical Co. Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of DongKook Pharmaceutical Co. Ltd. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

DongKook Pharmaceutical Co. Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of DongKook Pharmaceutical Co. Ltd. The current macd is -69.78935514.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the DongKook Pharmaceutical Co. Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for DongKook Pharmaceutical Co. Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the DongKook Pharmaceutical Co. Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
DongKook Pharmaceutical Co. Ltd Daily Moving Average Convergence/Divergence (MACD) ChartDongKook Pharmaceutical Co. Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of DongKook Pharmaceutical Co. Ltd. The current adx is 20.42.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell DongKook Pharmaceutical Co. Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
DongKook Pharmaceutical Co. Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of DongKook Pharmaceutical Co. Ltd. The current sar is 17,690.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
DongKook Pharmaceutical Co. Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of DongKook Pharmaceutical Co. Ltd. The current rsi is 44.27. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
DongKook Pharmaceutical Co. Ltd Daily Relative Strength Index (RSI) ChartDongKook Pharmaceutical Co. Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of DongKook Pharmaceutical Co. Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the DongKook Pharmaceutical Co. Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
DongKook Pharmaceutical Co. Ltd Daily Stochastic Oscillator ChartDongKook Pharmaceutical Co. Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of DongKook Pharmaceutical Co. Ltd. The current cci is -79.98552298.

DongKook Pharmaceutical Co. Ltd Daily Commodity Channel Index (CCI) ChartDongKook Pharmaceutical Co. Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of DongKook Pharmaceutical Co. Ltd. The current cmo is -17.09985744.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
DongKook Pharmaceutical Co. Ltd Daily Chande Momentum Oscillator (CMO) ChartDongKook Pharmaceutical Co. Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of DongKook Pharmaceutical Co. Ltd. The current willr is -55.95854922.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that DongKook Pharmaceutical Co. Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
DongKook Pharmaceutical Co. Ltd Daily Williams %R ChartDongKook Pharmaceutical Co. Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of DongKook Pharmaceutical Co. Ltd.

DongKook Pharmaceutical Co. Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of DongKook Pharmaceutical Co. Ltd. The current atr is 553.71.

DongKook Pharmaceutical Co. Ltd Daily Average True Range (ATR) ChartDongKook Pharmaceutical Co. Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of DongKook Pharmaceutical Co. Ltd. The current obv is 3,251,974.

DongKook Pharmaceutical Co. Ltd Daily On-Balance Volume (OBV) ChartDongKook Pharmaceutical Co. Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of DongKook Pharmaceutical Co. Ltd. The current mfi is 49.30.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
DongKook Pharmaceutical Co. Ltd Daily Money Flow Index (MFI) ChartDongKook Pharmaceutical Co. Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for DongKook Pharmaceutical Co. Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-07-31STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-08-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-30STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-10STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-08MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-16STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-18MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-10-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-10-31CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-11-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

DongKook Pharmaceutical Co. Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of DongKook Pharmaceutical Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.266
Ma 20Greater thanMa 5017,597.500
Ma 50Greater thanMa 10017,412.800
Ma 100Greater thanMa 20017,611.500
OpenGreater thanClose17,440.000
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of DongKook Pharmaceutical Co. Ltd with someone you think should read this too:
  • Are you bullish or bearish on DongKook Pharmaceutical Co. Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about DongKook Pharmaceutical Co. Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about DongKook Pharmaceutical Co. Ltd

I send you an email if I find something interesting about DongKook Pharmaceutical Co. Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about DongKook Pharmaceutical Co. Ltd.

Receive notifications about DongKook Pharmaceutical Co. Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.